METOLOSE® SR 90SH-15000SR provides a genuine consistency in Sustained release (matrix tablets). It can be used for semi solid drug products. For Hydrophilic matrix formulation of API and METOLOSE® SR to extend the dissolution. The dosage forms can be obtained by direct compression or granulation process. METOLOSE® SR has specifications of particle size which can be suitable for sustained release application. Dissolution profile can be easily adjusted by selecting appropriate grade. Recommendable amount of METOLOSE® SR is more than 20% in the formulation in order to form the stable gel layer.

BOVIDONE® K30 is a freely soluble, hygroscopic powder with high adhesive ability and excellent solubilization properties. It serves as an ideal binder for solid preparations, including wet and dry granulation, direct pressing, and fluidized bed granulation. It is particularly suitable for quick-release and anhydrous preparations, as well as drugs with poor water solubility, water sensitivity, or poor compressibility. BOVIDONE® K30 enhances tablet compressibility, adhesion, and hardness, promoting better drug release. Additionally, it is used as a coating agent to improve drug stability, as a suspension stabilizer for oral liquid formulations, and as a solubilizer to increase the bioavailability of insoluble drugs.

Klucel™ EXF Ultra Pharm is an ultra-fine hydroxypropylcellulose (HPC) binder optimized for oral solid dosage forms in pharmaceutical applications. Delivering enhanced tablet binding efficiency, it ensures formulation predictability, reliability, and robustness. With superior flow properties and broad compatibility, it supports high-performance drug delivery solutions, making it a preferred choice for pharmaceutical manufacturers.